How is the Regulus Therapeutics Inc today?

The Regulus Therapeutics Inc today is trading in the down by -0.25% at 7.93.

How has Regulus Therapeutics Inc performed historically?

The Regulus Therapeutics Inc is currently trading down -0.25% on an intraday basis in the past week the index rose 1.15%. The index has been up 524.41% in the past quarter and rose 294.53% in the past year. You can view this in the overview section.

What is Regulus Therapeutics Inc Annual Net Profit?

Regulus Therapeutics Inc Annual Net Profit fell 54.34% in the last year to $46.36 M. Its sector's average net profit growth for the last fiscal year was -11.16%.

What is Regulus Therapeutics Inc Price to Earning Ratio?

Regulus Therapeutics Inc Price to Earning Ratio is -11.55, which is negative.

What is Regulus Therapeutics Inc Stock Price?

Regulus Therapeutics Inc Stock Price rose 294.53% and outperformed its sector by 282.51% in the past year.

What is Regulus Therapeutics Inc Quarterly Net profit?

Regulus Therapeutics Inc Quarterly Net profit fell 13.76% YoY to $9.63 M. Its sector's average net profit growth YoY for the quarter was -200.49%.

What is Regulus Therapeutics Inc Debt to Equity Ratio?

Regulus Therapeutics Inc Debt to Equity Ratio is zero as the company is debt-free.

What is Regulus Therapeutics Inc Return on Equity(ROE)?

Regulus Therapeutics Inc Return on Equity(ROE) for the last financial year was -95.01%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Regulus Therapeutics Inc Mutual Fund Holding?

Regulus Therapeutics Inc Mutual Fund Holding decreased by 1.58% in the last quarter to 54.34.

What is Regulus Therapeutics Inc Promoter Share Holding?

Regulus Therapeutics Inc Promoter Share Holding increased by 1.82% in the most recent quarter to 8.77%.

What is Regulus Therapeutics Inc Interest Coverage Ratio?

Regulus Therapeutics Inc Interest Coverage Ratio is -292.4, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Regulus Therapeutics Inc Institutional Holding?

Regulus Therapeutics Inc Institutional Holding decreased by 1.71% in the last quarter to 76.25.

Regulus Therapeutics Inc XNAS: RGLS

Regulus Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Regulus Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Regulus Therapeutics Inc
Rating: 2.03883325
Author: Trendlyne DVM scores

about

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is ...

7.93 -0.02 (-0.25%)

Near 52W High of $8.20

555.4K XNAS Volume

XNAS 21 May, 2025 3:38 PM (EDT)

Board Meeting

The next board meeting for Regulus Therapeutics Inc is on 23 May 2025 for the purpose of Regulus Therapeutics Inc Annual General Meeting for 2024 See details

Not Eligible

Expensive Valuation

2.8 / 100

Technically Bullish

78.7 / 100

No estimates available

Regulus Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Regulus Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is ...

Near 52W High of $8.20

SWOT Analysis

Regulus Therapeutics Inc Live Price Chart

Regulus Therapeutics Inc FAQ

How is Regulus Therapeutics Inc today?

Regulus Therapeutics Inc today is trading in the red, and is down by -0.25% at 7.93.

How has Regulus Therapeutics Inc performed historically?

Regulus Therapeutics Inc is currently trading down -0.25% on an intraday basis. In the past week the stock rose 1.15%. stock has been up 524.41% in the past quarter and rose 294.53% in the past year. You can view this in the overview section.